<https://rdf.molmedb.upol.cz/reference/ref4226> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495171>,
		<https://identifiers.org/molmedb/MM494714>;
	<http://purl.org/ontology/bibo/pmid> "34855405"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494715>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.1c01504"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495312>,
		<https://identifiers.org/molmedb/MM494803>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>;
	<http://purl.org/dc/terms/bibliographicCitation> "Meng W, Pi Z, Brigance R, Rossi KA, Schumacher WA, Bostwick JS, Gargalovic PS, Onorato JM, Luk CE, Generaux CN, Wang T, Wexler RR, Finlay HJ.: Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure. J Med Chem, Volume 64 (24), 2021"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1020867> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4226> .
<https://rdf.molmedb.upol.cz/interaction/int1020673> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4226> .
<https://rdf.molmedb.upol.cz/interaction/int1021623> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4226> .
<https://rdf.molmedb.upol.cz/interaction/int1021479> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4226> .
<https://rdf.molmedb.upol.cz/interaction/int1020674> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4226> .
